Effect of seasonal influenza and COVID‐19 vaccination on severity and long‐term outcomes of patients with heart failure decompensations

Òscar Miró,Nicole Ivars,Begoña Espinosa,Javier Jacob,Aitor Alquézar‐Arbé,María Pilar López‐Díez,Pablo Herrero Puente,María Luisa López‐Grima,Beatriz Rodríguez,Pablo Rodríguez Fuertes,Pascual Piñera Salmerón,Josep Tost,Juan Antonio Andueza,Eva Domingo Baldrich,José Manuel Garrido,José Noceda,Francisco Javier Lucas‐Imbernon,Rocío Moyano García,Víctor Gil,Josep Masip,W. Frank Peacock,Christian Mueller,Pere Llorens,on behalf of the ICA‐SEMES group (see Appendix),Marta Fuentes,Aitor Davila,Sonia del Amo,Héctor Alonso,Enrique Pérez‐Llantada,Francisco Javier Martín‐Sánchez,Òscar Miró,Víctor Gil,Rosa Escoda,Carolina Sánchez,Daniel Repullo,Marta Masso,Javier Millán,Leticia Serrano,José Pavón,Nayra Cabrera González,Rafael Calvo Rodríguez,Juan Antonio Vega Reyes,María Luisa López‐Grima,Amparo Valero,María Ángeles Juan,Alfons Aguirre,Silvia Mínguez Masó,Virginia Fernández‐Távora Pérez,Ana Belén Mecina,Josep Tost,Susana Sánchez Ramón,Virginia Carbajosa Rodríguez,Pascual Piñera,José Andrés Sánchez Nicolás,Paula Lázaro Aragüés,Raquel Torres Garate,Esther Álvarez Rodríguez,Pilar Paz Arias,Aitor Alquézar‐Arbé,Sergio Herrera,Carlos José Romero Carrete,Javier Jacob,Alex Roset,Irene Cabello,Antonio Haro,Lidia Fuentes,Fernando Richard,Elisa Fernández,María Pilar López Diez,Pablo Herrero Puente,Joaquín Vázquez Álvarez,Belén Prieto García,Alejandra Fernández Fernández,Belén Álvarez Ramos,Natalia Fernández Miranda,Pere Llorens,Begoña Espinosa,Gema Jara,Alba Felipe,Adriana Gil,Juan Antonio Andueza,Rodolfo Romero,Mariella Luengo López,Gema Domínguez,Martín Ruíz,Beatriz Amores Arriaga,Beatriz Sierra Bergua,Enrique Martín Mojarro,Lidia Cuevas Jiménez,Lisette Travería Bécquer,Guillermo Burillo,Lluís Llauger García,Carmen Agüera Urbano,María de los Ángeles González de la Torre,Carmen Esmeralda Romero Jiménez,Ester Soy Ferrer,María Adroher Múñoz,José Manuel Garrido,Francisco Javier Lucas‐Imbernón,Rut Gaya,Carlos Bibiano,María Mir,Beatriz Rodríguez,Monika Vicente Martín,Esther Rodríguez Adrada,Eva Domingo Baldrich,Marianela Guzmán Carvajal,María José Fortuny,Yelenis Gómez García,Verónica de las Nieves Segura Coronill,Marco Antonio Esquivias,María del Carmen Martínez Picón,Rocío Moyano García,Pablo Rodríguez,María Martínez Cuevas,José Noceda,Santiago Harris Blasco,Marta Romero,Oriol Aguiló Pedret,Jordi Estopá Valladares

DOI: https://doi.org/10.1002/ejhf.3469

2024-09-25

European Journal of Heart Failure

Abstract:Influenza and COVID‐19 vaccination in patients with acute heart failure (AHF). CI, confidence interval; ED, emergency department; HR, hazard ratio; ICU, intensive care unit; OR, odds ratio. Aims To investigate whether seasonal influenza and COVID‐19 vaccinations influence the severity of decompensations and long‐term outcomes of patients with acute heart failure (AHF). Methods and results We included consecutive AHF patients attended at 40 Spanish emergency departments during November and December 2022. They were grouped according to whether they had received seasonal influenza and COVID‐19 vaccination. The severity of heart failure (HF) decompensation was assessed with the MEESSI scale, need for hospitalization, intensive care unit (ICU) admission, and in‐hospital mortality. Long‐term outcomes were 90‐day and 1‐year all‐cause mortality. Associations between vaccination, HF decompensation severity, and long‐term outcomes were investigated. Subgroup analyses were executed for 16 patient characteristics and their relationship with vaccination and 1‐year mortality. We analysed 4243 patients (median age 85 years; interquartile range 77–90; 57% female): 1841 (43%) had received influenza vaccination, 3139 (74%) COVID‐19 vaccination, 1773 (41.8%) received both vaccines (full vaccination) and 1036 (24.4%) none. Previous episodes of AHF, chronic obstructive pulmonary disease and chronic treatment with diuretics were associated with vaccination (either influenza, COVID‐19 and full vaccination). High or very‐high risk decompensation occurred in 18.6%; hospitalization in 72.3%, ICU admission in 1.1%, and in‐hospital mortality in 8.4%. Influenza vaccination was associated with lower hospitalization rates (adjusted odds ratio [OR] 0.746, 95% confidence interval [CI] 0.636–0.876) and in‐hospital mortality (OR 0.761, 95% CI 0.583–0.992), while COVID‐19 vaccination was associated with increased hospitalizations (OR 1.215, 95% CI 1.016–1.454). Overall, 90‐day and 1‐year mortality were 20.3% and 34.4%. Both were decreased in influenza‐vaccinated patients (adjusted hazard ratio [HR] 0.831, 95% CI 0.709–0.973; and HR 0.885, 95% CI 0.785–0.999, respectively) but only at 90 days in COVID‐19 vaccinated patients (HR 0.829, 95% CI 0.702–0.980). Full vaccination achieved even greater reductions in in‐hospital, 90‐day, and 1‐year mortality (HR 0.638, 95% CI 0.479–0.851; HR 0.702, 95% CI 0.592–0.833; and HR 0.815, 95% CI 0.713–0.931, respectively). Subgroup analysis based on patient‐related characteristics demonstrated the consistence of vaccination with long‐term survival. Conclusion In HF patients, seasonal influenza vaccination appears to be associated with less severe decompensation and lower 1‐year mortality, while no firm conclusions can be drawn from the results of the present study regarding the benefits of COVID‐19 vaccination. Full vaccination is associated with the greatest reduction in short‐ and long‐term mortality.

cardiac & cardiovascular systems